SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
AlterDiag has signed a long-term strategic partnership agreement with the Institut Pasteur for the development of new single-domain antibodies-based rapid...
FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of...
Survey of 600+ Global Physicians Also Finds on Average Physicians Spend 22 Personal Hours a Month Learning New Healthcare Technology...
Survey of 600+ Global Physicians Also Finds on Average Physicians Spend 22 Personal Hours a Month Learning New Healthcare Technology...
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/...
NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.SANTA ANA, Calif., Feb....
WARSAW, Poland, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The White Paper was unveiled on 21 February 2025 at the Medical...
BENGALURU, India and LONDON and SEATTLE, Feb. 19, 2025 /PRNewswire/ -- Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a 'Born Digital ....
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The Eye Health Summit, a new global patient-centered event dedicated to integrative...
Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic...
SHANGHAI, Feb. 17, 2025 /PRNewswire/ -- Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare...
Company Raises $3.85M in Seed Funding led by Caduceus Capital Partners, with Participation from Bread and Butter Ventures; Announces Collaboration...
EDEN PRAIRIE, Minn., Feb. 13, 2025 /PRNewswire/ -- Starkey continues to be at the forefront of technology and innovation and...
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global remote patient monitoring market, valued at US$24.39 billion in 2023,...
Ad hoc announcement pursuant to Art. 53 LR AGAMREE® is the first product to receive an agreed federal price in...
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food...
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics...
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics...
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat PlatformSARASOTA, Fla....